COMPASS Act

Bill: 115-hr-5716
Sponsor: Rep. Roskam, Peter J. [R-IL-6]
Introduced: 2018-05-09 in the House
Policy area: Health
Subjects: Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health care costs and insurance
Health information and medical records
Medicare
Prescription drugs

Summary:
action_date: 2018-05-09
text: 

Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act or the COMPASS Act

 
This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids.

action_date: 2018-06-12
text: 

Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act or the COMPASS Act

 
This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids.


Legislative actions:
action_date: 2018-06-12
text: Placed on the Union Calendar, Calendar No. 574.
action_date: 2018-06-12
text: Committee on Ways and Means discharged.
action_date: 2018-06-12
text: Committee on Ways and Means discharged.
action_date: 2018-06-12
text: Reported by the Committee on Energy and Commerce. H. Rept. 115-740, Part I.
action_date: 2018-06-12
text: Reported by the Committee on Energy and Commerce. H. Rept. 115-740, Part I.
action_date: 2018-05-23
text: Referred to the Subcommittee on Health.
action_date: 2018-05-17
text: Ordered to be Reported by Voice Vote.
action_date: 2018-05-17
text: Committee Consideration and Mark-up Session Held.
action_date: 2018-05-09
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-05-09
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-05-09
text: Introduced in House
action_date: 2018-05-09
text: Introduced in House